MEDEX Report issue

Contributed to NME For profit Phase 2 Phase 3
Founded: Chula Vista CA United States (1967)
Status: Acquired by Smiths Medical, ASD, Inc. (2005) → now ICU Medical Inc (2021)

Organization Overview

First Clinical Trial
2005
NCT00199979
First Marketed Drug
2014
naltrexone (revia)
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Medex Healthcare Research, Inc. | MEDEXUS

Active Ingredients

Marketed Drugs (1)

naltrexone (revia) (2014)

Drugs in Phase 3 Trials (1)

nevirapine (viramune) (1 trial)

Drugs in Phase 2 Trials (1)

peramivir (rapivab) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

HIV Infections (Phase 3)

Influenza, Human (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 2